NASDAQ:SPPI

Shares Of Spectrum Pharmaceuticals, Inc (NASDAQ:SPPI) Plunge After A Failed Trial

Spectrum Pharmaceuticals, Inc (NASDAQ:SPPI) has lately been going through difficult times. The most tragic point was when the biopharma pronounced the failure of the drugs in the Phase II trial. These had been targeted towards the treatment of very severe lung cancer. The test confirmed that the drug did not meet the required endpoint, something […]